Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 69 (4), 415-23

Duration of Immunity Following Immunization With Live Measles Vaccine: 15 Years of Observation in Zhejiang Province, China

Affiliations

Duration of Immunity Following Immunization With Live Measles Vaccine: 15 Years of Observation in Zhejiang Province, China

B Dai et al. Bull World Health Organ.

Abstract

The duration of immunity following measles vaccination of 2882 immunized children has been investigated in a closed region of China for 15 years. A total of 1002 of the children were treated as primary immunization subjects, and 1547 as reimmunization subjects. These two cohorts were not in contact with known wild measles virus over the whole observation period, and the results obtained probably reflected the antibody responses to measles vaccine alone. The remaining 333 vaccinees came into contact with wild measles virus, and this permitted evaluation of the protective effect of the measles vaccines tested: 4 children experienced very mild clinical measles, and 329 experienced subclinical infection, including 12 who had had undetectable haemagglutination-inhibition antibodies for 9-10 years. These results indicate that the immunity induced by successful primary immunization may persist for at least 15 years. Within this period, a second dose of vaccine only induces low antibody responses which decrease rapidly to their original levels. This provides strong evidence that the immunity produced by primary immunization is long-lasting. However, there were some indications that reimmunization might produce better effects if live attenuated measles virus were used with a longer interval between doses.

PIP: The duration of immunity following measles vaccination of 2882 immunized children has been investigated in a closed region of China for 15 years. A total of 1002 children were treated as primary immunization subjects, and 1547 as reimmunization subjects. These 2 cohorts had no contact with known wild measles virus over the entire observation period, and the results obtained probably reflected the antibody responses to measles vaccine alone. The remaining 333 vaccines came into contact with wild measles virus, and this allowed for the evaluation of the protective effect of the measles vaccines tested. 4 children experienced very mild clinical measles and 329 experienced subclinical infection, including 12 who had had undetectable hemagglutination-inhibition antibodies for 9-10 years. These results indicate that the immunity induced by successful primary immunization may persist for at least 15 years. Within this period of time, a 2nd dose of vaccine only induces low antibody responses which decreases rapidly to their original levels. This demonstrates strong evidence that the immunity produced by primary immunization is long lasting. However, there were indications that reimmunization might produce better results if live attenuated measles virus were used with a longer interval between doses.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

References

    1. Br Med J (Clin Res Ed). 1987 Jul 4;295(6589):22-4 - PubMed
    1. Biken J. 1986 Mar;29(1):19-26 - PubMed
    1. Vaccine. 1986 Sep;4(3):173-8 - PubMed
    1. JAMA. 1976 Jan 5;235(1):31-4 - PubMed
    1. Rev Infect Dis. 1983 May-Jun;5(3):477-81 - PubMed

Publication types

Feedback